These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34517306)

  • 41. Clinical outcomes and prognostic factors of concurrent chemoradiotherapy for anal squamous cell carcinoma in Japan.
    Takahashi R; Osumi H; Wakatsuki T; Yamamoto N; Taguchi S; Nakayama I; Ooki A; Ogura M; Takahari D; Chin K; Yamaguchi K; Shinozaki E
    Int J Clin Oncol; 2024 Aug; 29(8):1161-1172. PubMed ID: 38819609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence and Prognostic Significance of HPV in Laryngeal Squamous Cell Carcinoma in Northeast China.
    Tong F; Geng J; Yan B; Lou H; Chen X; Duan C; He J; Zhang S; Xie H; Li H; Yuan D; Zhang F; Meng H; Wei L
    Cell Physiol Biochem; 2018; 49(1):206-216. PubMed ID: 30134232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human papillomavirus in oropharyngeal squamous cell carcinomas in Korea: use of G1 cycle markers as new prognosticators.
    Park WS; Ryu J; Cho KH; Choi MK; Moon SH; Yun T; Chun BS; Lee GK; Ahn HJ; Lee JH; Vermeer P; Jung YS
    Head Neck; 2012 Oct; 34(10):1408-17. PubMed ID: 22052559
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival.
    Wittekindt C; Gültekin E; Weissenborn SJ; Dienes HP; Pfister HJ; Klussmann JP
    Adv Otorhinolaryngol; 2005; 62():72-80. PubMed ID: 15608419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-risk HPV DNA status and p16 (INK4a) expression as prognostic markers in patients with squamous cell cancer of oral cavity and oropharynx.
    Śnietura M; Jaworska M; Pigłowski W; Goraj-Zając A; Woźniak G; Lange D
    Pol J Pathol; 2010; 61(3):133-9. PubMed ID: 21225495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multimodal assessment of high-risk human papillomavirus in sinonasal squamous cell carcinoma.
    Zhou A; Sharma A; Kuhnell D; Hinrichs BH; Kendler A; Wang J; Dillehey-McKillip K; Tang AL; Takiar V; Wise-Draper TM; Langevin SM
    Pathol Res Pract; 2024 Sep; 261():155486. PubMed ID: 39088875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy.
    Yhim HY; Lee NR; Song EK; Kwak JY; Lee ST; Kim JH; Kim JS; Park HS; Chung IJ; Shim HJ; Hwang JE; Kim HR; Nam TK; Park MR; Shim H; Park HS; Kim HS; Yim CY
    Int J Cancer; 2011 Oct; 129(7):1752-60. PubMed ID: 21128253
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53.
    Meulendijks D; Tomasoa NB; Dewit L; Smits PH; Bakker R; van Velthuysen ML; Rosenberg EH; Beijnen JH; Schellens JH; Cats A
    Br J Cancer; 2015 Apr; 112(8):1358-66. PubMed ID: 25871546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HPV Infection and Anemia Status Stratify the Survival of Early T2 Laryngeal Squamous Cell Carcinoma.
    Wang H; Zhang Z; Sun R; Lin H; Gong L; Fang M; Hu WH
    J Voice; 2015 May; 29(3):356-62. PubMed ID: 25484261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. p53 and p16
    Mohanty SK; Mishra SK; Bhardwaj N; Sardana R; Jaiswal S; Pattnaik N; Pradhan D; Sharma S; Kaushal S; Baisakh MR; Das S; Pradhan MR; Satapathy K; Pattnaik A; Sharma SK; Khadenga CR; Das S; Rath D; Nanda B; Parwani AV
    Clin Genitourin Cancer; 2021 Dec; 19(6):510-520. PubMed ID: 34348854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
    Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
    J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The study of the combination detection of HPV-DNA and p16INK4a in cervical lesions.
    Huang MZ; Huang S; Li DQ; Nie XM; Li HB; Jiang XM
    Med Oncol; 2011 Dec; 28 Suppl 1():S547-52. PubMed ID: 21053103
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study.
    McAlpine JN; Leung SCY; Cheng A; Miller D; Talhouk A; Gilks CB; Karnezis AN
    Histopathology; 2017 Aug; 71(2):238-246. PubMed ID: 28257152
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Double Positivity for HPV DNA/P16
    Alsharif U; Hofmann M; Gebhard M; Tharun L; Rades D; Sieg P; Hakim SG
    Anticancer Res; 2021 Nov; 41(11):5557-5568. PubMed ID: 34732426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
    Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
    Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human papillomavirus as a favorable prognostic biomarker in squamous cell carcinomas of the vagina.
    Alonso I; Felix A; Torné A; Fusté V; del Pino M; Castillo P; Balasch J; Pahisa J; Rios J; Ordi J
    Gynecol Oncol; 2012 Apr; 125(1):194-9. PubMed ID: 22226684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of human papillomavirus in p16-positive oral cancers.
    Belobrov S; Cornall AM; Young RJ; Koo K; Angel C; Wiesenfeld D; Rischin D; Garland SM; McCullough M
    J Oral Pathol Med; 2018 Jan; 47(1):18-24. PubMed ID: 29024035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combining routine morphology, p16(INK4a) immunohistochemistry, and in situ hybridization for the detection of human papillomavirus infection in penile carcinomas: a tissue microarray study using classifier performance analyses.
    Chaux A; Cubilla AL; Haffner MC; Lecksell KL; Sharma R; Burnett AL; Netto GJ
    Urol Oncol; 2014 Feb; 32(2):171-7. PubMed ID: 23499169
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer.
    Reimers N; Kasper HU; Weissenborn SJ; Stützer H; Preuss SF; Hoffmann TK; Speel EJ; Dienes HP; Pfister HJ; Guntinas-Lichius O; Klussmann JP
    Int J Cancer; 2007 Apr; 120(8):1731-8. PubMed ID: 17236202
    [TBL] [Abstract][Full Text] [Related]  

  • 60. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
    Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
    Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.